Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

New SpectraScience board: The light-based biopsy system maker announced Jan. 12 that is has established an advisory board chaired by former Wisconsin Governor and Health and Human Services Secretary Tommy Thompson to "assist and direct management in facing requirements of a changing health care system." SpectraScience markets the WavSTAT optical biopsy system and the LUMA cervical imaging tool. [Editor's note: The original version of this brief incorrectly identified the company creating the new advisory board.

You may also be interested in...



People Briefs: InVivo Therapeutics CEO Resigns; CVPath Institute, Harvard Bioscience Appoint New CEOs

InVivo Therapeutics Holdings Corp. chairman and CEO resigns. CVPath Institute and Harvard Bioscience get new CEOs. Cook Medical appoints VP to lead its aortic intervention clinical division. Sunshine Heart names chief medical officer.

Correction

Gen-Probe: In the Jan. 18, 2010 issue (1p. 14), a "J.P. Morgan Healthcare Conference In Brief" item incorrectly notes that Gen-Probe plans to submit a 510(k) to FDA for its Aptima HPV assay to run on its Tigris system. The company plans to submit a PMA

Regeneration/Tutogen Merger Creates Broad Biologic Implant Portfolio

Regeneration Technologies Inc. will maintain both the BioCleanse and Tutoplast tissue sterilization processes for making biologic implants following its acquisition of Tutogen in a $263 million stock-swap deal, announced Nov. 13

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel